Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quantitative determination of nucleoside analogue drugs in genomic DNA or RNA

Quantitative determination of nucleoside analogue drugs in genomic DNA or RNA

US Patent 11035850 · Granted Jun 15, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Induction of synthetic lethality with epigenetic therapy2025
Agents for reversing epigenetic silencing of genes2024
Induction of synthetic lethality with epigenetic therapy2022
Agents for reversing epigenetic silencing of genes2019
DNA methylation markers for metastatic prostate cancer2019
5-hydroxymethylcytosine in human cancer2016
Agents for reversing epigenetic silencing of genes2015